Northeast Pharmaceutical Group Co Ltd (000597) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.049x

Based on the latest financial reports, Northeast Pharmaceutical Group Co Ltd (000597) has a cash flow conversion efficiency ratio of 0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥274.09 Million ≈ $40.11 Million USD) by net assets (CN¥5.60 Billion ≈ $819.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Northeast Pharmaceutical Group Co Ltd (000597) balance sheet quality index to measure how much of total assets are equity-financed.

Northeast Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Northeast Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 000597 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Northeast Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Northeast Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dazhong Transportation Group Co Ltd A SHG:600611	0.028x
Jiangsu Tongxingbao Intelligent Transportation Technology Co. Ltd. A SHE:301339	N/A
Inner Mongolia ERDOS Resources Co Ltd B SHG:900936	0.075x
Xinzhi Motor Co Ltd SHE:002664	-0.004x
SY HOLDINGS GROUP HD-01 F:9U0	N/A
Cardinal Infrastructure Group Inc. Class A Common Stock NASDAQ:CDNL	0.000x
Chengdu Spaceon Electronics Co Ltd Class A SHE:002935	-0.067x
Hanma Technology Group Co Ltd SHG:600375	-0.016x

Annual Cash Flow Conversion Efficiency for Northeast Pharmaceutical Group Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Northeast Pharmaceutical Group Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Northeast Pharmaceutical Group Co Ltd (000597) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥5.67 Billion ≈ $829.59 Million	CN¥1.11 Billion ≈ $161.90 Million	0.195x	+43.25%
2024-12-31	CN¥5.57 Billion ≈ $815.01 Million	CN¥758.76 Million ≈ $111.03 Million	0.136x	+19.78%
2023-12-31	CN¥5.16 Billion ≈ $754.89 Million	CN¥586.75 Million ≈ $85.86 Million	0.114x	-51.64%
2022-12-31	CN¥4.71 Billion ≈ $689.70 Million	CN¥1.11 Billion ≈ $162.22 Million	0.235x	+35.17%
2021-12-31	CN¥4.29 Billion ≈ $627.80 Million	CN¥746.51 Million ≈ $109.24 Million	0.174x	+25.63%
2020-12-31	CN¥4.12 Billion ≈ $603.21 Million	CN¥570.92 Million ≈ $83.54 Million	0.138x	+53.89%
2019-12-31	CN¥3.92 Billion ≈ $573.30 Million	CN¥352.60 Million ≈ $51.60 Million	0.090x	+13.42%
2018-12-31	CN¥3.59 Billion ≈ $525.75 Million	CN¥285.09 Million ≈ $41.72 Million	0.079x	+167.13%
2017-12-31	CN¥2.55 Billion ≈ $372.85 Million	CN¥-301.20 Million ≈ $-44.07 Million	-0.118x	-174.83%
2016-12-31	CN¥2.43 Billion ≈ $356.17 Million	CN¥384.51 Million ≈ $56.27 Million	0.158x	+280.44%
2015-12-31	CN¥2.40 Billion ≈ $351.34 Million	CN¥99.70 Million ≈ $14.59 Million	0.042x	+144.00%
2014-12-31	CN¥2.76 Billion ≈ $404.05 Million	CN¥46.99 Million ≈ $6.88 Million	0.017x	+110.22%
2013-12-31	CN¥1.60 Billion ≈ $233.99 Million	CN¥-266.38 Million ≈ $-38.98 Million	-0.167x	-438.70%
2012-12-31	CN¥1.75 Billion ≈ $256.13 Million	CN¥86.09 Million ≈ $12.60 Million	0.049x	+136.74%
2011-12-31	CN¥1.74 Billion ≈ $255.03 Million	CN¥-233.32 Million ≈ $-34.14 Million	-0.134x	-208.03%
2010-12-31	CN¥2.07 Billion ≈ $302.24 Million	CN¥255.96 Million ≈ $37.46 Million	0.124x	-58.68%
2009-12-31	CN¥2.05 Billion ≈ $300.50 Million	CN¥615.91 Million ≈ $90.13 Million	0.300x	-33.40%
2008-12-31	CN¥1.57 Billion ≈ $230.40 Million	CN¥709.03 Million ≈ $103.75 Million	0.450x	+101.66%
2007-12-31	CN¥889.22 Million ≈ $130.12 Million	CN¥198.56 Million ≈ $29.06 Million	0.223x	+295.39%
2006-12-31	CN¥927.49 Million ≈ $135.72 Million	CN¥-106.00 Million ≈ $-15.51 Million	-0.114x	-192.34%
2005-12-31	CN¥900.07 Million ≈ $131.71 Million	CN¥111.40 Million ≈ $16.30 Million	0.124x	-48.16%
2004-12-31	CN¥884.02 Million ≈ $129.36 Million	CN¥211.06 Million ≈ $30.88 Million	0.239x	-9.70%
2003-12-31	CN¥870.26 Million ≈ $127.35 Million	CN¥230.08 Million ≈ $33.67 Million	0.264x	+46.67%
2002-12-31	CN¥873.28 Million ≈ $127.79 Million	CN¥157.41 Million ≈ $23.03 Million	0.180x	+101.95%
2001-12-31	CN¥883.36 Million ≈ $129.26 Million	CN¥78.84 Million ≈ $11.54 Million	0.089x	+123.72%
2000-12-31	CN¥905.53 Million ≈ $132.51 Million	CN¥36.13 Million ≈ $5.29 Million	0.040x	-36.48%
1999-12-31	CN¥869.73 Million ≈ $127.27 Million	CN¥54.62 Million ≈ $7.99 Million	0.063x	+926.23%
1998-12-31	CN¥999.14 Million ≈ $146.21 Million	CN¥-7.59 Million ≈ $-1.11 Million	-0.008x	--

About Northeast Pharmaceutical Group Co Ltd

SHE:000597 China Drug Manufacturers - Specialty & Generic

Market Cap

$964.78 Million

CN¥6.59 Billion CNY

Market Cap Rank

#8950 Global

#2155 in China

Share Price

CN¥4.62

Change (1 day)

+0.87%

52-Week Range

CN¥4.20 - CN¥6.09

All Time High

CN¥133.00